Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.320
+0.080 (6.45%)
At close: Apr 1, 2025, 4:00 PM
1.319
-0.001 (-0.08%)
After-hours: Apr 1, 2025, 5:07 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $93.20 million as of April 1, 2025. Its market cap has decreased by -33.72% in one year.
Market Cap
93.20M
Enterprise Value
35.80M
1-Year Change
-33.72%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $93.20M, a decrease of -93.07%. That is a compound annual growth rate of -23.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 34.70M | -80.74% |
| Dec 31, 2024 | 180.20M | 5.26% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |